World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal

BACKGROUND: Burkina Faso is a high endemicity country for HBV infection. However, there are few data on vaccine coverage against HBV. The aim of this study was to contribute to the improvement of HBV vaccine coverage in Ouagadougou through HBV screening. METHODS: Awareness campaigns and voluntary he...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Virol J
Autori principali: Diarra, Birama, Yonli, Albert Theophane, Ouattara, Abdoul Karim, Zohoncon, Theodora Mahoukèdè, Traore, Lassina, Nadembega, Christelle, Obiri-Yeboah, Dorcas, Yara, Justine, Pietra, Virginio, Ouedraogo, Paul, Bougouma, Alain, Sanogo, Rokia, Simpore, Jacques
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2018
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6080359/
https://ncbi.nlm.nih.gov/pubmed/30081915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-018-1032-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi